These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29448119)

  • 1. Estimation of hepatic fat fraction using modified Dixon magnetic resonance imaging techniques: effect of liver cirrhosis.
    Min J; Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    Clin Imaging; 2018; 51():50-58. PubMed ID: 29448119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.
    Hetterich H; Bayerl C; Peters A; Heier M; Linkohr B; Meisinger C; Auweter S; Kannengießer SA; Kramer H; Ertl-Wagner B; Bamberg F
    Eur Radiol; 2016 Jun; 26(6):1895-904. PubMed ID: 26340812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.
    Satkunasingham J; Besa C; Bane O; Shah A; de Oliveira A; Gilson WD; Kannengiesser S; Taouli B
    Eur J Radiol; 2015 Aug; 84(8):1452-1458. PubMed ID: 26047820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 1H MR spectroscopy, 3-point DIXON, and multi-echo gradient echo for measuring hepatic fat fraction.
    Ishizaka K; Oyama N; Mito S; Sugimori H; Nakanishi M; Okuaki T; Shirato H; Terae S
    Magn Reson Med Sci; 2011; 10(1):41-8. PubMed ID: 21441727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between incidental fat deposition in the liver and pancreas in asymptomatic individuals.
    Aliyari Ghasabeh M; Shaghaghi M; Khoshpouri P; Pan L; Pandy A; Pandy P; Zhong X; Kannengiesser S; Kamel IR
    Abdom Radiol (NY); 2020 Jan; 45(1):203-210. PubMed ID: 31482380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.
    Kang BK; Kim M; Song SY; Jun DW; Jang K
    Br J Radiol; 2018 Sep; 91(1089):20170378. PubMed ID: 29022777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.
    Kukuk GM; Hittatiya K; Sprinkart AM; Eggers H; Gieseke J; Block W; Moeller P; Willinek WA; Spengler U; Trebicka J; Fischer HP; Schild HH; Träber F
    Eur Radiol; 2015 Oct; 25(10):2869-79. PubMed ID: 25903702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE
    J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?
    Parente DB; Rodrigues RS; Paiva FF; Oliveira Neto JA; Machado-Silva L; Lanzoni V; Campos CF; Eiras-Araujo AL; do Brasil PE; Garteiser P; Gomes MB; de Mello Perez R
    PLoS One; 2014; 9(11):e112574. PubMed ID: 25426708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat Quantification in the Vertebral Body: Comparison of Modified Dixon Technique with Single-Voxel Magnetic Resonance Spectroscopy.
    Lee SH; Yoo HJ; Yu SM; Hong SH; Choi JY; Chae HD
    Korean J Radiol; 2019 Jan; 20(1):126-133. PubMed ID: 30627028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive hepatic fat quantification: Can multi-echo Dixon help?
    Gupta A; Dixit R; Prakash A
    Radiol Bras; 2024; 57():e20230125. PubMed ID: 38993969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D Multiecho Dixon for the Evaluation of Hepatic Iron and Fat in a Clinical Setting.
    Henninger B; Zoller H; Kannengiesser S; Zhong X; Jaschke W; Kremser C
    J Magn Reson Imaging; 2017 Sep; 46(3):793-800. PubMed ID: 28225576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.